Profound Medical Corp.
PROF
$4.78
$0.061.27%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.33M | -9.36M | -6.92M | -6.20M | -8.66M |
| Total Depreciation and Amortization | 212.00K | 223.00K | 242.00K | 259.00K | 82.00K |
| Total Amortization of Deferred Charges | -136.00K | 45.00K | 45.00K | 46.00K | -- |
| Total Other Non-Cash Items | -566.00K | 730.00K | 956.00K | 768.00K | 1.06M |
| Change in Net Operating Assets | 182.00K | 2.00M | -674.00K | 28.00K | 188.00K |
| Cash from Operations | -5.64M | -6.36M | -6.35M | -5.10M | -7.33M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -523.00K | -665.00K | -676.00K | -696.00K | -203.00K |
| Issuance of Common Stock | 39.21M | 0.00 | 1.00K | 22.94M | 4.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.04M | 0.00 | 0.00 | -1.86M | -- |
| Cash from Financing | 35.65M | -665.00K | -675.00K | 20.38M | -199.00K |
| Foreign Exchange rate Adjustments | -2.22M | 72.00K | -76.00K | -318.00K | 116.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 27.79M | -6.96M | -7.10M | 14.97M | -7.41M |